·
15 MIN READ

Bobby Mukkamala, MD, on tangible actions to reverse the overdose epidemic

The AMA is leading the fight against the COVID-19 pandemic. See video updates on how the AMA is fighting COVID-19 by discussing actions to reverse the overdose epidemic.

series
Overdose Epidemic
AMA Update
·
15 MIN READ

July 8, 2022: National Advocacy Update

Senate HELP Committee urged to consider MAT Act and more in the latest National Advocacy Update.

Advocacy Update
·
5 MIN READ

AMA adopts new policies on final day of Special Meeting

New positions address telehealth confidentiality, medical student training and prescription drug monitoring programs.

Press Releases
Two people with arms extended out grasping hands
·
4 MIN READ

5 evidence-based steps to end the overdose epidemic

Shame and stigma won’t save lives. Learn with the AMA about what effective policy looks like.

Overdose Epidemic
Interior hallway of a hospital with sign pointing to 'emergency' department.
·
4 MIN READ

44% drop in opioid Rx since 2011, but overdoses spike. Here’s why.

Learn what’s really driving the worsening epidemic of drug-related overdoses and deaths, and how the AMA is working fervently to end it.

Overdose Epidemic
·
12 MIN READ

Bobby Mukkamala, MD, reviews the 2021 Overdose Epidemic Report

AMA's Moving Medicine series features physician voices and achievements. Learn more in this discussion with Bobby Mukkamala, MD, on findings from the 2021 Overdose Epidemic Report.

series
Overdose Epidemic
Moving Medicine Video Update
·
4 MIN READ

Top news stories from AMA Morning Rounds®: Week of Sept. 20, 2021

In the news: COVID-19 booster shots for patients 65+ and those at high risk, administration addressing public health linked to extreme heat, 2021 Overdose Epidemic Report.

Publications & Newsletters
·
4 MIN READ

Report shows decreases in opioid prescribing, increase in overdoses

The AMA is urging policymakers to join physicians to reduce mortality and improve patient outcomes by removing barriers to evidence-based care.

Press Releases
·
1 MIN READ

AMA statement on Justice Department settlement with Purdue Pharma

Any settlement should be used exclusively for data collection, research, education, overdose prevention, stigma elimination, and evidence-based treatment.

Press Releases